» Articles » PMID: 12677142

Rating the Risk Factors for Breast Cancer

Overview
Journal Ann Surg
Specialty General Surgery
Date 2003 Apr 5
PMID 12677142
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To update and summarize evidence of risk factors for breast cancer.

Summary Background Data: Women who are at high risk for breast cancer have a variety of options available to them, including watchful waiting, prophylactic surgery, and chemoprevention. It is increasingly important to accurately assess a patient's risk profile to ensure that the cost/benefit ratio of the selected treatment is favorable.

Methods: Estimates of relative risk for documented risk factors were obtained from seminal papers identified in previous reviews. These estimates were updated where appropriate with data from more recent reports using large sample sizes or presenting meta-analyses of previous studies. These reports were identified from a review of the Medline database from 1992 to 2002.

Results: Risk factors that have received a great deal of publicity (hormone use, alcohol consumption, obesity, nulliparity) present a relatively modest relative risk for breast cancer (<2). Factors associated with a prior history of neoplastic disease or atypical hyperplasia and factors associated with a genetic predisposition significantly affect the risk of breast cancer, with relative risks ranging from 3 (for some cases of positive family history) to 200 (for premenopausal women positive for a BRCA mutation).

Conclusions: More precise tools, based on techniques of molecular biology such as microarray analysis, will be needed to assess individual risk for breast cancer.

Citing Articles

Downregulation of DNAJC12 Expression Predicts Worse Survival for ER-Positive Breast Cancer Patients.

Gatti P, Mangone F, Pavanelli A, Nonogaki S, Osorio C, Capelozzi V Biomark Insights. 2025; 20:11772719251323095.

PMID: 40008192 PMC: 11851741. DOI: 10.1177/11772719251323095.


Per- And Poly-Fluoroalkyl Substances (PFAS) Exposure and Risk of Breast, and Female Genital Cancers: A Systematic Review and Meta-Analysis.

Seyyedsalehi M, Maria Kappil E, Zhang S, Zheng T, Boffetta P Med Lav. 2024; 115(6):e2024043.

PMID: 39697081 PMC: 11734636. DOI: 10.23749/mdl.v115i6.16330.


Systematic Meta-Analysis of Computer-Aided Detection of Breast Cancer Using Hyperspectral Imaging.

Leung J, Karmakar R, Mukundan A, Thongsit P, Chen M, Chang W Bioengineering (Basel). 2024; 11(11).

PMID: 39593720 PMC: 11591395. DOI: 10.3390/bioengineering11111060.


Potential Role of Glyphosate, Glyphosate-Based Herbicides, and AMPA in Breast Cancer Development: A Review of Human and Human Cell-Based Studies.

Schluter H, Bariami H, Park H Int J Environ Res Public Health. 2024; 21(8).

PMID: 39200696 PMC: 11354939. DOI: 10.3390/ijerph21081087.


Epidemiological breast cancer prediction by country: A novel machine learning approach.

El Haji H, Sbihi N, Guermah B, Souadka A, Ghogho M PLoS One. 2024; 19(8):e0308905.

PMID: 39141659 PMC: 11324133. DOI: 10.1371/journal.pone.0308905.


References
1.
Assersohn L, Gangi L, Zhao Y, Dowsett M, Simon R, Powles T . The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses. Clin Cancer Res. 2002; 8(3):794-801. View

2.
. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet. 1999; 350(9084):1047-59. View

3.
Ellis M, Davis N, Coop A, Liu M, Schumaker L, Lee R . Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses. Clin Cancer Res. 2002; 8(5):1155-66. View

4.
Euhus D, Cler L, Shivapurkar N, Milchgrub S, Peters G, Leitch A . Loss of heterozygosity in benign breast epithelium in relation to breast cancer risk. J Natl Cancer Inst. 2002; 94(11):858-60. DOI: 10.1093/jnci/94.11.858. View

5.
Nelson H, Humphrey L, Nygren P, Teutsch S, Allan J . Postmenopausal hormone replacement therapy: scientific review. JAMA. 2002; 288(7):872-81. DOI: 10.1001/jama.288.7.872. View